HeartBeam, Inc. (BEAT): A Bull Case Theory
We came across a bullish thesis on HeartBeam, Inc. (BEAT) on Triple S Special Situations Investing’s Substack by TripleS Special Situations.
Cardionet Inc (BEAT)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Sophrosyne Capital Benjamin J Taylor | 0 | $0 | 0% | |
| 2. | Trigran Investments Douglas T. Granat | 0 | $0 | 0% | |
| 3. | Camber Capital Management Stephen Dubois | 0 | $0 | 0% | |
| 4. | PEAK6 Capital Management Matthew Hulsizer | 0 | $0 | 0% | |
| 5. | Algert Coldiron Investors Peter Algert And Kevin Coldiron | 0 | $0 | 0% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $0.00 | 5,000 | Director | 134,550 | 2013-02-19 | Filing | |
| $2.22 | 15,000 | Director | 129,550 | 2012-11-12 | Filing | |
| $2.22 | 15,000 | Director | 164,336 | 2012-11-12 | Filing | |
| $2.17 | 10,745 | Officer, Director | 350,355 | 2012-09-05 | Filing | |
| $2.32 | 12,795 | Officer, Director | 339,610 | 2012-09-04 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Relationship | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.76 | 300 | Officer | 24,184 | 2010-08-13 | Filing | |
| $25.75 | 5,670 | Director | 9,611 | 2009-02-26 | Filing | |
| $25.76 | 741 | Director | 15,281 | 2009-02-26 | Filing | |
| $25.77 | 158 | Director | 16,022 | 2009-02-26 | Filing | |
| $25.79 | 52 | Director | 16,180 | 2009-02-26 | Filing |
Institutional Investors' Holdings
News See All
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2024 Earnings Call Transcript
Operator: Greetings, and welcome to the HeartBeam Second Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2024 Earnings Call Transcript
Operator: Greetings. And welcome to the HeartBeam First Quarter 2024 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2023 Earnings Call Transcript
HeartBeam, Inc. misses on earnings expectations. Reported EPS is $-0.15 EPS, expectations were $-0.12.
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2023 Earnings Call Transcript
Operator: Greetings and welcome to the HeartBeam Third Quarter 2023 Financial Results Conference Call. [Operator Instructions] A question-and-answer session will follow the formal presentation.
HeartBeam, Inc. (NASDAQ:BEAT) Q2 2023 Earnings Call Transcript
Operator: Greetings and welcome to the HeartBeam Second Quarter 2023 Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded.
HeartBeam, Inc. (NASDAQ:BEAT) Q1 2023 Earnings Call Transcript
Operator: Greetings and welcome to the HeartBeam First Quarter 2023 Financial Results Conference Call. At this time all participants are in listen only mode.
HeartBeam, Inc. (NASDAQ:BEAT) Q4 2022 Earnings Call Transcript
Operator: Greetings. And welcome to the HeartBeam Fourth Quarter and Full-Year 2022 Financial Results Conference Call. At this time, all participants are in a listen-only mode.
Is BEAT A Good Stock To Buy Now?
At Insider Monkey, we pore over the filings of nearly 817 top investment firms every quarter, a process we have now completed for the latest reporting period.
Is BioTelemetry, Inc. (BEAT) A Good Stock To Buy?
Insider Monkey has processed numerous 13F filings of hedge funds and successful value investors to create an extensive database of hedge fund holdings.